US Microbiology Testing Market

  • August 2011
  • -
  • Venture Planning Group

Highlights

  • Comprehensive 1,087-page analysis of the US microbiology testing market.
  • Major issues pertaining to the US microbiology laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
  • Current scientific views on the definition, epidemiology, and etiology of major infectious diseases and microorganisms.
  • Ten-year test volume and sales forecasts for nearly 80 microbiology tests performed in US hospitals, blood banks, physician offices, public health and commercial laboratories.
  • Instrumentation technologies and feature comparison of leading analyzers.
  • Sales and market shares of leading suppliers.
  • Emerging diagnostic technologies and their potential market applications.
  • Product development opportunities.
  • Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
  • Business opportunities and strategic recommendations for suppliers.

Contains 1,037 pages and 177 tables

Table Of Contents

Table of Contents

Introduction
Worldwide Market and Technology Overview
A. Major Infectious Disease Tests
1. AIDS
a. Background
Structure and Composition
Classification
Origin of AIDS
Animal Lentivirus Systems
Virus Receptos
HIV Infections in Humans
Pathogenesis and Pathology: Overview of
HIV Infection Course
CD4T Lymphocytes and Memory Cells
Monocytes and Macrophages
Lymphoid Organs
Neural Cells
Viral Coinfections
Clinical Findings
Plasma Viral Load
Pediatric AIDS
Neurologic Disease
Opportunistic Infections
Cancer
Immunity
Virus Isolation
Serology
Detection of Viral Nucleic
Acid and Antigens
Infectivity
Epidemiology
Worldwide Spread of AIDS
United States
Routes of Transmission
b. Diagnostic Tests
Laboratory Diagnosis
Enzyme Immunoassay Interpretation
Specific, Sensitivity, and Predictive
Value of Enzyme Immunoassays
Competition Assays
Western Blot Technique
ImmunoFluorescence Assay (IFA)
Radioimmunoprecipitation
HIV1/HIV2 Combination Testing
Methods of HIVAntigen Detection
Antigen Assays and Blood Screening
Urine Tests
Immunopathogenic Mechanism of HIV Infection
DNA Probes
Overview
Quantitative Polymerase Chain Reaction
In Situ PCR
Needed Improvements
Viral Load/Drug Resistance Testing
Genotype and Phenotype Testing
Blood Banking Consideration
c. Vaccines and Drugs
Antiviral Drugs
Vaccines Against HIV
Transmission of HIV in Blood Products
HIV Transmission in Transplant and
Artificial Insemination Recipients
2. Adenovirus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
d. AdenoAssociated Viruses(AAV)
3. Aeromonas
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
4. Anthrax/Bacillus Anthracis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
5. Arboviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
6. Babesiosis
a. Background
7. Bacillary Epithelioid Angiomatosis (BEA)
And Other Bartonella (Rochalimaea)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
8. Blastocystis Hominis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
9. Brucella
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
1. Campylobacter
a. Background
b. Diagnostic Tests
Identification from Culture
c. Vaccines and Drugs
11. Candida
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
12. Chagas Disease
a. Background
13. Chancroid
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
14. Chlamydia
a. Background
Chlamydia Psittaci
Chlamydia Pneumoniae
Chlamydia Trachomatis
b. Diagnostic Tests
c. Vaccines and Drugs
15. Clostridium Difficile
a. Background
Pediatric Infections
Epidemiology
b. Diagnostic Tests
Counterimmuno electrophoresis
Fluorescent Antibody Assays
Poloymerase Chain Reactions
c. Drugs and Vaccines
16. Coronaviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
17. Coxsackieviruses
a. Background
Herpangina
Handfootandmouth syndrome
Hepidemic Conjuctivitis
Pharingitis
Epidemic Pleurodynia
Myodarditis,Pericarditis
Overwhelming Infection of the Newborn
Acute Aseptic Meningitis
Undifferentiated Febrile Illness
Fever with upper respiratory infection
Encephalitis
Asymptomatic Infection
b. Diagnostic Tests
c. Vaccines and Drugs
18. CreutzfeldtJakob’s Disease
a. Background
Blood Transmission
b. Diagnostic Tests
Major Commercial and Academic Players
Bayer
Disease Sciences/Bio Tec Global
Imperial College of Medicine
OrthoClinical Diagnostics
Pall
ProMetic Life Sciences
Proteome Sciences/Idexx
QOne Biotech
Serono
U.S. Agricultural Research Service
c. Vaccines
19. Cryptosporidium Parvum
a. Background
b. Diagnostic Tests
Histologic
Laboratory Parasitology
Serodiagnosis
c. Vaccines and Drugs
2. Cyclospora Cayetanensis
a. Background
Asymptomatic Infection
Diarrhea in Immunocompetent Persons
Diarrhea in Immunocompromisedersons
b. Diagnostic Tests
c. Vaccines and Drugs
21. Cytomegalovirus
a. Background
Chorioretinitis
Gastrointestinal
Central Nervous System Disease
b. Diagnostic Tests
c. Vaccines and Drugs
22. Ebola Virus
a. Background
Epidemiology
Hemorrhagic Fever
b. Diagnostic Tests
c. Vaccines and Drugs
23. E. Coli
a. Background
Role of Escherichia Coli in Causing Diarrhea
EPEC
ETEC
EIEC
EHEC
b. Diagnostic Tests
c. Vaccines and Drugs
24. EchoVirus
a. Background
Acute Aseptic Miningitisis
Encephalitis
Exanthems
Respiratory Disease
Myope;ricarditis
Neonatal Infections
b. Diagnostic Tests
c. Vaccines and Drugs
25. Encephalitis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
26. Enteroviruses
a. Background
b. Diagnostic Tests
Viral Isolation and Identification
Antibody Tests
c. Vaccines and Drugs
27. EpsteinBarr Virus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
28. Giardia Lamblia
a. Background
Life Cycle and Morphology
Morphology of Trophozoites
Clinical Disease
b. Diagnostic Tests
c. Vaccines and Drugs

29. Gonorrhea
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
3. Granuloma Inguinale
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
31. Hantavirus
a. Background
Identification of the Agent
Transmission
Other Rodent Hantaviruses
Distribution
Hantavirus Diseases
Epidemiology
Addendum in ProofNortheastern Connection
Previously Unknown Pathogens
Cases Nationwide
b. Diagnostic Tests
An Immunohistochemistry Approach
Hantavirus Rapid Diagnostic Test
ELISA Diagnosis of Hantavirus Pulmonary
Syndrome
IgG ELISA
IgM Capture ELISA
c. Vaccines and Drugs
32. Helicobacter Pylori
a. Background
Pathogenesis
Role in Peptic Ulcer Disease
Role in Gastric Cancer
Nonulcer Dyspepsia
b. Diagnostic Tests
c. Vaccines and Drugs
Specific Therapeutic Regimens
Who Should Be Treated?
Participants in Controlled Clinical Trials
Patients with Refractory Peptic Ulcer
Patients with Refractory NUD
Patients in HighRisk Groups for Gastric
Cancer
33. Hepatitis
a. Background
b. Hepatitis A
c. Hepatitis B
d. Hepatitis C
Classification
Transmission of Infection
Occupational Hazards
Acute Hepatitis
Diagnosis of Acute Infection
Chronic Hepatitis
HCV and Other Chronic Liver Diseases
Alcoholic Liver Disease
Hepatitis B Coinfection
Cirrhosis and Hepatocellular Carcinoma
Diagnostic Tests
Possible Indications for HCV RNA Testing
Conclusions and Future Direction
e. Hepatitis D
Historical Perspective
Epidemiology
HBVHDV "Coinfection" vs. "Superinfection"
Methods of Detecting HDV
Prevention
f. Hepatitis E
Background
Prevalence of the Disease
Diagnostic Tests
Epidemiologic Serosurveys
Serologic CrossReactivity
g. Hepatitis G
Vaccines and Drugs
34. Herpes Simplex Virus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
35. Human Herpes Virus6 (HHV6)
a. Background
HIV6 Infections
b. Diagnostic Tests
c. Vaccines and Drugs
36. Influenza Viruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
37. Legionella
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
38. Lyme Disease
a. Background
Clinical Description
Clinical Case Definition
Laboratory Criteria for Diagnosis
Case Classification
b. Diagnostic Tests
c. Vaccines and Drugs
39. Lymphogranuloma Venereum (LGV)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
4. Malaria
a. Background
b. Diagnostic Tests
Potential Diagnositic Problems with Positive Patients from Nonendemic Areas
Patient
Laboratory
Physician
c. Vaccines and Drugs
41. Measles (Rubeola)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
42. Meningitis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
Development of Polysaccharide Vaccines
Quadrivalent Vaccine Development
Meningococcal A.C.Y. and W135 Vaccines
Efficacy of Group C Vaccine
Efficacy of Group A Vaccine
Combinations of Group A and C Vaccines
Group B Efficacy Trials
Future Direction
43. Microsporidium
a. Background
Prevalence and Geographic Distribution
Sources of Human Infection and Transmission
b. Diagnostic Tests
Light Microscopic Examination of Stool Specimens By Chromotrope Staining Stool Concentration Methods
Chemofluorescent Agents
Giemsa Staining of Stool Specimens
Cytologic Diagnosis
Histologic Examination
Electron Microscopy
Examination of Bodily Fluids
Examination of Tissue Sections
Immunofluorescence Detection Procedures
Serology
Cell Culture
Approach to Diagnosis
Evaluation of Patients with Presumptive
Intestinal Microsporidiosis
Evaluation of Patients with Presumptive
Ocular Microsporidiosis
c. Vaccines and Drugs
44. Mononucleosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
45. Mumps
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
Efficacy of Vaccination
Future Issues
46. Mycoplasma
a. Background
Ureaplasma Urealyticum and Mycoplasma Hominis
b. Diagnostic Tests
c. Vaccines and Drugs
47. Papillomaviruses
a. Background
HPV in Cancer
Cervical Neoplasm
b. Diagnostic Tests
c. Vaccines and Drugs
Prevention
48. Parvovirus B19
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
49. Pneumonia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
5. Polyomaviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
51. Pseudomonas Aeruginosa
a. Background
Virulence Factors
b. Diagnostic Tests
c. Vaccines and Drugs
52. Rabies
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
53. Respiratory Syncytial Virus (RSV)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
54. RhinoViruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
55. RotaVirus (REOVIRUS)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
56. Rubella(MEASLES)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
Developing Countries
Elimination and Eradication of Measles
New Developments
57. Salmonellosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
58. Septicemia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
59. Shigellosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
6. Staphylococcus Aureus
a. Background
The Genus Taphylococcus
b. Diagnostic Tests
c. Vaccines and Drugs
Prevention
61. Streptococci
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
Group A Streptococci
Group B Streptococci
62. Syphilis
a. Background
b. Diagnostic Tests
Biopsy
Rabbit Infectivity Testing
Other Diagnostic Modalities
c. Vaccines and Drugs
Syphilis and HIV Infection
Syphilis As a Cofactor for HIV Transmission
Basic Science Issues
63. Toxoplasmosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
64. Trichomonas Vaginalis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
65. Tuberculosis
a. Background
b. Diagnostic Tests
Microscopic Characteristics
Cultural Characteristics
Detection of Antibodies
Skin Tests
MDRTB
c. Vaccines and Drugs
66. Vibrio
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
67. West Nile Virus
a. Background
Clinical Syndromes
b. Diagnostic Tests
c. Vaccines and Drugs
68. Yersina
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
B. Instrumentation Review and Market Needs
Abbott AxSYM
Abbott IMx/IMx Select
Anagen AN2/AuraFlex
Beckman Coulter Access
BioChem Pharma/SR1
BioMerieux/Vitek Vidas
Biotrol System 7
Chiron ACS: Centaur
Chiron ACS: 18
JandJ Diagnostics/Amersham Amerlite
JandJ Diagnostics Vitros ECi
Olympus PK31
Roche Cobas Core
Roche Elecsys 11/21
Roche ES 22
Roche ES 33
Roche ES 3/3AL
Siemens ELISA Processor II/III
Siemens Immuno 1
Siemens/Opus/Plus/Magnum
Siemens Stratus
Tosoh AIA12/12DX/NexIA/6
Wallac/Pharmacia Delfia
C. Emerging Diagnostic Technologies
1. DNA Probes
a. Technology Overview
b. Amplification Methods
Polymerase Chain Reaction
Robotics
Temperature Cyclers
PCR Variations
ImmunoPCR
QCPCR
DAPPCR
Ligase Chain Reaction
Branched DNA
QBeta Replicase
NucleicAcid SequenceBased
Strand Displacement Activation
SelfSustained Sequence Replicase
2. Monoclonal Antibodies
3. Immunoassays
a. Technological Principle
b. Enzyme Immunoassays (EIA)
Overview
ELISA
Dot Immunobinding Assays
Capillary Immunoassays
ParticleMembrane Capture
Immunoassays
Enzyme Amplification
c. Fluorescent Immunoassays
Fluorescence Polarization
TimeResolved Pulse Fluorescence
d. Luminescence
Chemiluminescence
Bioluminescence
e. Latex Agglutination
f. Immunoprecipitation
4. Differential Light Scattering
5. Microcomputers and Automation
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
1. MRI
11. Gel Microdroplets
12. Other
D. Personal Testing
E. Worldwide Business Environment
F. Worldwide Market Structure
G. Worldwide Market Size and Growth
U.S.A.
A. Executive Summary
B. Business Environment
1. Health Care Expenditures
2. Cost Consciousness
3. Reimbursement
4. Industry Consolidation
5. Managed Care
a. HMO
b. PPO
6. Hospitals
7. Admissions
8. Length of Stay
9. Industry Diversification
1. Physician Demographics
11. Population Aging
a. Chronic Illness
b. Disease Incidence
c. Susceptibility to Iatrogenesis
d. Multiple Illness Cases
12. Laboratory Regulations
13. FDA Reform
C. Market Structure
1. Centralized Testing
a. Hospitals
b. Commercial/Private Laboratories
c. Blood Banks
1) Community and Regional Centers
2) Plasma Fractionation Centers
2. Decentralized Testing
a. Physician Offices/Group Practices
b. Point of Care Testing
c. Other Decentralized Testing Locations
D. Market Size, Growth and Major Suppliers
Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Computers, Software and Automation
D. Auxiliary Products
Design Criteria for Decentralized Testing Products
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Competitive Assessments
Abbott
Affymetrix
Beckman Coulter
Becton Dickinson
bioMerieux
BioRad
Cepheid
Diamedix
DiaSorin
Eiken Chemical
Enzo Biochem
Fujirebio
GenProbe
Hologic
ID Biomedical
JandJ Diagnostics
Kreatech
Life Technology
Lonza
Nanogen
Novartis Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac
Wako

List of Tables
Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Adenovirus Tests
Major Companies Developing or Marketing Bartonella Tests
Major Companies Developing or Marketing
Campylobacter Tests
Major Companies Developing or Marketing Candida Tests
Major Companies Developing or Marketing Chlamydia Tests
Major Companies Developing or Marketing Clostridium Tests
Major Companies Developing or Marketing Coronavirus Tests
Major Companies Developing or Marketing Cryptosporidium Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Echovirus Tests
Major Companies Developing or Marketing Enterovirus Tests
Major Companies Developing or Marketing EBV Tests

Major Companies Developing or Marketing Giardia Tests
Major Companies Developing or Marketing Gonorrhea Tests
Major Companies Developing or Marketing Hantavirus Tests
Major Companies Developing or Marketing Helicobacter Pylori Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing Herpes Tests
Major Companies Developing or Marketing Influenza Tests
Major Companies Developing or Marketing Legionella Tests
Major Companies Developing or Marketing Lyme Disease Tests
Major Companies Developing or Marketing Lymphogranuloma Tests
Major Companies Developing or Marketing Malaria Tests
Major Companies Developing or Marketing Measles Tests
Major Companies Developing or Marketing Meningitis Tests
Major Companies Developing or Marketing Microsporidium Tests
Major Companies Developing or Marketing Mononucleosis Tests
Major Companies Developing or Marketing Mumps Tests
Major Companies Developing or Marketing Mycoplasma Tests
Major Companies Developing or Marketing Papilloma Virus Tests
Major Companies Developing or Marketing Parvovirus Tests
Major Companies Developing or Marketing Pneumonia Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Rotavirus Tests
Major Companies Developing or Marketing Rubella Tests
Major Companies Developing or Marketing Salmonella Tests
Major Companies Developing or Marketing Septicemia Tests
Major Companies Developing or Marketing Shigella Tests
Major Companies Developing or Marketing Staphylococci Tests
Major Companies Developing or Marketing Streptococci Tests
Major Companies Developing or Marketing Syphilis Tests
Major Companies Developing or Marketing Toxoplasmosis Tests
Major Companies Developing or Marketing Trichomonas Tests
Major Companies Developing or Marketing Tuberculosis Tests
Major Companies Developing or Marketing West Nile Tests
Major Companies Developing or Marketing Yersinia Tests
Worldwide All Market Segments Laboratories Performing Microbiology Tests by Country
Worldwide All Market Segments Total Microbiology Test Volume Forecast by Country
Worldwide All Market Segments Total Microbiology Diagnostics Market Forecast by Country
Infectious Disease Tests Major Issues and Market
Potential For Personal Testing
U.S.A. Summary Table
All Infectious Diseases Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A.
Laboratories Performing Infectious Disease Tests by Market Segment
U.S.A.
Hospital Laboratories Performing Infectious Disease Tests by Bed Size
U.S.A.
Commercial/Private Laboratories Performing Infectious Disease Tests by Annual Test Volume
U.S.A.
Physician Office Laboratories Performing Infectious Disease Tests by Practice Size
U.S.A.
All Market Segments Infectious Disease Test Volume Forecast
U.S.A.
Hospital Laboratories Infectious Disease Test Volume Forecast
U.S.A.
Blood Banks Infectious Disease Test Volume Forecast
U.S.A.
Physician Office Laboratories Infectious Disease Test Volume Forecast
U.S.A.
Commercial/Private Laboratories Infectious Disease Test Volume Forecast
U.S.A.
Public Health Laboratories Infectious Disease Test Volume Forecast
U.S.A.
All Market Segments Infectious Disease Diagnostics Market Forecast
U.S.A.
Hospital Laboratories Infectious Disease Diagnostics Market Forecast
U.S.A.
Blood Banks Infectious Disease Diagnostics Market Forecast
U.S.A.
Physician Office Laboratories Infectious Disease Diagnostics Market Forecast
U.S.A.
Commercial/Private Laboratories Infectious Disease Diagnostics Market Forecast
U.S.A.
Public Health Laboratories Infectious Disease Diagnostics Market Forecast
U.S.A.
HIV or HIVI/HIVII Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
HTLV I or HTLV I/HTLV II Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
HIVAg Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Western Blot/Other Confirmatory Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Adenovirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Aeromonads Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.
BEA Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Blastocystis Hominis Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Campylobacter Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Candida Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Clostridium Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Coronavirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
CoxsackieVirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Cryptosporidium Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Cyclospora Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
CMV Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
E. Coli Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Echovirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Encephalitis Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Enterovirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
EBV Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Giardia Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Granuloma Inguinale Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Hantavirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Helicobacter Pylori Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
HAV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
HBV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
HbsAg Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Hepatitis C Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
AntiHBC Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
AntiHBS Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
AntiHAV Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Hepatitis Delta Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
HBcAg Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
HBeAg Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
ALT/SGPT Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Influenza Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Legionella Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Lyme Disease Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Lymphogranuloma Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Malaria Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Measles Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Meningitis Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Microsporidium Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Mononucleosis Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Mumps Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Papilloma Virus Test Volume and Diagnostics Sales Forecast by Market Segment
U.s.a.
Parvovirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Pneumonia Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Polyomaviruses Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Pseudomonas Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Rabies
Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
RSV
Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Rhinovirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Rotavirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Rubella Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Salmonella Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Septicemia Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Shigella Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Staphylococci Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Streptococci Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Toxoplasmosis Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Trichomonas Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Tuberculosis Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Vibrio Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
West Nile Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
Yersinia Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A.
AIDS Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Adenovirus Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Campylobacter Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Candida Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Chancroid Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Chlamydia Testing Market Diagnostics Sales by Major Supplier
U.S.A.
CMV Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Cryptosporidium Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Echovirus Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Enterovirus Testing Market Diagnostics Sales by
Major Supplier
U.S.A.
EBV Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Giardia Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Gonorrhea Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Helicobacter Pylori Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Hepatitis Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Hepatitis C Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Herpes Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Influenza Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Legionella Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Lyme Disease Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Measles Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Meningitis Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Mononucleosis Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Mumps Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Mycoplasma Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Pneumonia Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Rabies Testing Market Diagnostics Sales by Major Supplier
U.S.A.
RSV Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Rotavirus Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Rubella Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Salmonella Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Septicemia Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Shigella Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Streptococci Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Syphilis Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Toxoplasmosis Testing Market Diagnostics Sales by Major Supplier

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

2014 Market Segmentation Analysis of the Global Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations

2014 Market Segmentation Analysis of the Global Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations

  • $ 34 500
  • Industry report
  • July 2014
  • by Venture Planning Group

Complete report $34,500.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

Emerging Opportunities in the Global Virology and Bacteriology Testing Market

Emerging Opportunities in the Global Virology and Bacteriology Testing Market

  • $ 21 100
  • Industry report
  • June 2014
  • by Venture Planning Group

“Emerging Opportunities in the Global Virology and Bacteriology Testing Market” is a new seven-country strategic analysis of major business opportunities emerging in the infectious disease testing ...

Future Horizons and Growth Strategies in the Global Microbiology Testing Market 2014: Supplier Shares and Country Forecasts

Future Horizons and Growth Strategies in the Global Microbiology Testing Market 2014: Supplier Shares and Country Forecasts

  • $ 21 100
  • Industry report
  • August 2014
  • by Venture Planning Group

Complete report $32,500.  DataPack (test volumes, sales forecasts, supplier shares) $21,100. “2014 Strategies for the Global Microbiology Testing Market” is a new seven-country strategic analysis ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.